Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia
Somalia has suffered from a civil war during the last 10 years. In this period the use of whole blood has increased at least twofold in Mogadishu, Somalia compared with pre-war. Screening possibilities are limited. Recent data concerning the prevalence of infections with blood-borne and sexually tra...
Gespeichert in:
Veröffentlicht in: | Epidemiology and infection 2000-02, Vol.124 (1), p.137-141 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Somalia has suffered from a civil war during the last 10 years. In this period the use of whole
blood has increased at least twofold in Mogadishu, Somalia compared with pre-war. Screening
possibilities are limited. Recent data concerning the prevalence of infections with blood-borne
and sexually transmitted agents are not available from this country. To investigate the spread
of human immunodeficiency virus (HIV-1/2) and other blood-borne or sexually transmitted
agents we tested a total of 256 serum samples collected in the summer of 1995 from blood
donors, hospitalized children and adults in Mogadishu. The hepatitis B surface antigen
(HbsAg) carrier rate was 19·1%, 5·6% and 21·3% among blood donors, hospitalized children
and hospitalized adults, respectively. However, no children under 2 years of age were
HbsAg positive. The overall presence of antibodies against hepatitis C virus (HCV) was 2·4%
(6/256). In blood donors this was 0·6% (1/157). In none of the samples tested, antibodies
against HIV 1 and 2 or human T-cell lymphotropic viruses (HTLV I and II) were detected.
Our results indicate that, during the civil war in Somalia, no evidence of an increase of HIV
infections was found. Our findings indicate that preventive measures in Somalia should focus
mainly on prevention of HBV-infections. HBV-vaccine could be administered within the
framework of the expanded programme on immunization, as none of the children less than 2
years of age were HbsAg positive. |
---|---|
ISSN: | 0950-2688 1469-4409 |
DOI: | 10.1017/S0950268899003441 |